BioWorld

Jan. 23, 1998

View Archived Issues

McGill-Harvard Team Reports Strongest Prostate Cancer Risk Factor

Read More

J&J Pays Alkermes $30M For Sustained-Release EPO

Read More

CV Therapeutics Raises $19M For Cardiovascular Projects

Read More

Other News To Note

Read More

Federal Health Agencies Examine Xenotransplantation

Read More

Genentech's 1997 Revenues Crack $1B, Income Up 9 Percent

Read More